Review
Jul 2026
Digitalis bei Herzinsuffizienz – willkommen zurück?
Digitoxin (at low serum concentrations) is recommended for patients with HFrEF and persistent symptoms despite standard therapy, since, in contrast to digoxin, there are positive trial data demonstrating a reduction in mortality and heart failure hospitalizations.
U. Bavendiek, J. Bauersachs
· Die Innere Medizin · 0 citations